BlackRock Science and Technology Trust II vs Orsted A/S
A head-to-head of BlackRock Science and Technology Trust II (BSTZ) and Orsted A/S (DOGEF) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | BSTZ | DOGEF |
|---|---|---|
| Market Cap | $1.72B | $537.44B |
| P/E (TTM) | 2.94 | 126.35 |
| Forward P/E | 0.00 | 0.66 |
| P/S | 5.70 | 7.34 |
| P/B | 1.00 | 2.00 |
| EV/EBITDA | 0.00 | 15.58 |
| Dividend Yield | 17.06% | — |
| Profit Margin | 162.28% | 2.97% |
| Gross Margin | 92.26% | -2.70% |
| Operating Margin | 118.36% | -2.70% |
| Revenue Growth (YoY) | +94.50% | +12.75% |
| FCF Yield | -7.33% | -5.87% |
| Debt / Equity | 1.02 | 83.48 |
| Current Ratio | 1.82 | 1.94 |
Which is better: BlackRock Science and Technology Trust II or Orsted A/S?
- ✓Larger by market cap: Orsted A/S
- ✓Cheaper valuation (lower P/E): BlackRock Science and Technology Trust II
- ✓More profitable (net margin): BlackRock Science and Technology Trust II
- ✓Faster revenue growth: BlackRock Science and Technology Trust II
- ✓Higher free-cash-flow yield: Orsted A/S
Across 10 available metrics, BlackRock Science and Technology Trust II leads 8–2.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare BlackRock Science and Technology Trust II with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.